A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes

被引:44
作者
Hartman, Isamu Z. [1 ]
Kim, AeRyon [1 ]
Cotter, Robert J. [2 ]
Walter, Kimberly [3 ]
Dalai, Sarat K. [3 ]
Boronina, Tatiana [4 ]
Griffith, Wendell [2 ]
Lanar, David E. [5 ]
Schwenk, Robert [5 ]
Krzych, Urszula [5 ]
Cole, Robert N. [4 ,6 ]
Sadegh-Nasseri, Scheherazade [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
[5] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA
[6] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Inst Basic Biomed Sci, Baltimore, MD USA
基金
美国国家科学基金会;
关键词
LIVER-STAGE ANTIGEN-1; COLLAGEN TYPE-II; HLA-DM; PLASMODIUM-FALCIPARUM; MASS-SPECTROMETRY; T-CELLS; REMNANT EPITOPES; MHC MOLECULES; GELATINASE-B; CATHEPSIN-S;
D O I
10.1038/nm.2248
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Immunodominance is defined as restricted responsiveness of T cells to a few selected epitopes from complex antigens. Strategies currently used for elucidating CD4(+) T cell epitopes are inadequate. To understand the mechanism of epitope selection for helper T cells, we established a cell-free antigen processing system composed of defined proteins: human leukocyte antigen-DR1 (HLA-DR1), HLA-DM and cathepsins. Our reductionist system successfully identified the physiologically selected immunodominant epitopes of two model antigens: hemagglutinin-1 (HA1) from influenza virus (A/Texas/1/77) and type II collagen (CII). When applied for identification of new epitopes from a recombinant liver-stage antigen of malaria falciparum (LSA-NRC) or HA1 from H5N1 influenza virus ('avian flu'), the system selected single epitopes from each protein that were confirmed to be immunodominant by their capacity to activate CD4(+) T cells from H5N1-immunized HLA-DR1-transgenic mice and LSA-NRC-vaccinated HLA-DR1-positive human volunteers. Thus, we provide a new tool for the identification of physiologically relevant helper T cell epitopes from antigens.
引用
收藏
页码:1333 / U192
页数:9
相关论文
共 38 条
[1]
TRANSIENT ACCUMULATION OF NEW CLASS-II MHC MOLECULES IN A NOVEL ENDOCYTIC COMPARTMENT IN B-LYMPHOCYTES [J].
AMIGORENA, S ;
DRAKE, JR ;
WEBSTER, P ;
MELLMAN, I .
NATURE, 1994, 369 (6476) :113-120
[2]
Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes [J].
Beltrami, Alessandra ;
Rossmann, Maxim ;
Fiorillo, Maria Teresa ;
Paladini, Fabiana ;
Sorrentino, Rosa ;
Saenger, Wolfram ;
Kumar, Pravin ;
Ziegler, Andreas ;
Uchanska-Ziegler, Barbara .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (40) :27189-27199
[3]
Overalkylation of a protein digest with iodoacetamide [J].
Boja, ES ;
Fales, HM .
ANALYTICAL CHEMISTRY, 2001, 73 (15) :3576-3582
[4]
Endosomal proteases in antigen presentation [J].
Chapman, HA .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :78-84
[5]
PREDOMINANT NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR1 ARE DERIVED FROM MHC-RELATED MOLECULES AND ARE HETEROGENEOUS IN SIZE [J].
CHICZ, RM ;
URBAN, RG ;
LANE, WS ;
GORGA, JC ;
STERN, LJ ;
VIGNALI, DAA ;
STROMINGER, JL .
NATURE, 1992, 358 (6389) :764-768
[6]
HLA-DM recognizes the flexible conformation of major histocompatibility complex class II [J].
Chou, CL ;
Sadegh-Nasseri, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1697-1706
[7]
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+T cells but does not protect against experimental Plasmodium falciparum infection [J].
Cummings, James F. ;
Spring, Michele D. ;
Schwenk, Robert J. ;
Ockenhouse, Christian F. ;
Kester, Kent E. ;
Polhemus, Mark E. ;
Walsh, Douglas S. ;
Yoon, In-Kyu ;
Prosperi, Christine ;
Juompan, Laure Y. ;
Lanar, David E. ;
Krzych, Urszula ;
Hall, B. Ted ;
Ware, Lisa A. ;
Stewart, V. Ann ;
Williams, Jack ;
Dowler, Megan ;
Nielsen, Robin K. ;
Hillier, Collette J. ;
Giersing, Birgitte K. ;
Dubovsky, Filip ;
Malkin, Elissa ;
Tucker, Kathryn ;
Dubois, Marie-Claude ;
Cohen, Joe D. ;
Ballou, W. Ripley ;
Heppner, D. Gray, Jr. .
VACCINE, 2010, 28 (31) :5135-5144
[8]
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation [J].
Deussing, J ;
Roth, W ;
Saftig, P ;
Peters, C ;
Ploegh, HL ;
Villadangos, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4516-4521
[9]
FIDOCK DA, 1994, J IMMUNOL, V153, P190
[10]
Gebe John A., 2007, V136, P39